A compound discovered by UM researcher Jay Evans and his colleagues soon will begin human trials with cancer patients in Australia. (Tommy Martino/UM)
August 27, 2024
Stories this photo appears in:
August 28, 2024 midnight
Drug developed at University of Montana moves to cancer patient trials
MISSOULA – A compound discovered by the University of Montana Center for Translational Medicine has started Phase I clinical trials with cancer patients. The center’s partner in the effort is Inimmune Corp., a Missoula-based biotechnology company.